echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Blood lipoprotein levels are linked to the risk of ALS in the future

    Blood lipoprotein levels are linked to the risk of ALS in the future

    • Last Update: 2021-09-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A large epidemiological study published online in the Journal of Neurology, Neurosurgery and Psychiatry showed that some blood lipid biomarkers related to cardiovascular disease risk are also associated with lower risk of amyotrophic lateral sclerosis (ALS) Related


    Amyotrophic lateral sclerosis is the most common motor neuron disease.


    Single-gene factors only lead to a small number of ALS cases, and the etiology of the remaining cases is unclear


    Researchers are eager to find biomarkers associated with amyotrophic lateral sclerosis (ALS), which may eventually lead to earlier diagnosis, possibly before symptoms appear, and hopefully preventive treatment


    The authors used data from a large epidemiological study to try to determine the relationship between the levels of biomarkers related to cardiovascular disease and the subsequent diagnosis of ALS


    They used data from 502,409 people who participated in the UK Biobank study between March 2006 and October 2010.


    The authors studied the relationship between ALS and blood high and low density lipoproteins (HDL and LDL), total cholesterol, apolipoprotein A1 and B (apoA1 and apoB), triglycerides, glycosylated hemoglobin A1c (HbA1c), and creatinine


    After controlling for age and gender, the authors found that higher HDL and apoA1 were associated with lower ALS risk


    When a model containing multiple metabolic markers is used to assess disease risk, HDL and apoA1 continue to be associated with a reduction in ALS risk, which has nothing to do with other factors


    Further analysis showed that the levels of LDL and apoB were higher before the diagnosis, but lower in the population close to the diagnosis, while there was no such difference in the levels of HDL and apoA1


    The author said: "In models that control statin use, smoking, and vascular disease, these continuing findings indicate that the association between lipid levels and amyotrophic lateral sclerosis is not lipid, amyotrophic lateral sclerosis.


    This is an observational study, so the cause cannot be determined


    There are still some inconsistencies in other published studies, reflecting different methods


    "In addition to providing new insights into pathogenesis, this underscores the need to consider a wider range of potential pre-symptomatic biomarkers


    DOI

    10.


    Higher blood high density lipoprotein and apolipoprotein A1 levels are associated with reduced risk of developing amyotrophic lateral sclerosis


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.